AstraZeneca unveils latest research across key respiratory and immune-mediated diseases at ATS 20...

AstraZeneca unveils latest research across key respiratory and immune-mediated diseases at ATS 2024 showcasing strength of its broad pipeline and portfolio  AstraZeneca

A new commitment for vaccine equity and defeating the pandemic - World Bank Blogs

A new commitment for vaccine equity and defeating the pandemic  World Bank Blogs

Imfinzi regimen demonstrated statistically significant and clinically meaningful improvement in d...

Imfinzi regimen demonstrated statistically significant and clinically meaningful improvement in disease-free survival for high-risk non-muscle-invasive bladder cancer in POTOMAC Phase III trial  AstraZeneca

Enhertu plus pertuzumab demonstrated highly statistically significant and clinically meaningful i...

Enhertu plus pertuzumab demonstrated highly statistically significant and clinically meaningful improvement in progression-free survival vs. THP as 1st-line therapy for patients with HER2-positive metastatic breast cancer  AstraZeneca

Calquence Phase III ASCEND trial met primary endpoint at interim analysis in relapsed or refracto...

Calquence Phase III ASCEND trial met primary endpoint at interim analysis in relapsed or refractory chronic lymphocytic leukaemia and will stop early  AstraZeneca

AZD1222 vaccine met primary efficacy endpoint in preventing COVID-19 - AstraZeneca

AZD1222 vaccine met primary efficacy endpoint in preventing COVID-19  AstraZeneca

TAGRISSO™ (AZD9291) approved by the US FDA for patients with EGFR T790M mutation-positive metasta...

TAGRISSO™ (AZD9291) approved by the US FDA for patients with EGFR T790M mutation-positive metastatic non-small cell lung cancer  AstraZeneca

アストラゼネカ社ワクチン 使用中止の会見中に担当者が倒れる | TBS NEWS DIG (39QldzptPOZ) - folha do es

アストラゼネカ社ワクチン 使用中止の会見中に担当者が倒れる | TBS NEWS DIG (39QldzptPOZ)  folha do es

Warning as experts reveal deadly condition caused by single Covid jab - Daily Mail

Warning as experts reveal deadly condition caused by single Covid jab  Daily Mail